A multi-center, real-world study of up to 500 patients treated with the Carillon Mitral Contour System as standard of care.

Interim analysis of 228 prospective and retrospective patients with up to 5 years of follow-up for safety and efficacy.

This data confirms results from multiple clinical studies that the Carillon therapy has an excellent safety profile, sustained clinical and mechanistic efficacy benefits, and is associated with improved long-term term survival.